Cerner Corp (CERN)
$68.31
0.22 (0.32%)
CERN Stock Quote Delayed 15 Minutes
Previous Close
$68.09
Market Cap
22.67B
PE Ratio
27.00
EPS
2.53
Volume (Avg. Vol.)
340,763
Day's Range
67.72 - 68.44
52-Week Range
48.78 - 76.47
Dividend & Yield
N/A (N/A)
CERN Stock Predictions, Articles, and Cerner Corp News
Cerner Layoffs 2019: 16 Things to Know About the CERN Job Cuts
Cerner layoffs are on the way as the company looks to reduce its workforce and increasing its operating margin for Q4 2019.
The Failure of America’s Health-IT System and Amazon’s Opportunity
The real scandal isn't the failure of the stimulus but the response, which was to ditch open-source health-IT solutions that worked for proprietary ones that don't.
3 Stocks to Watch on Wednesday: Akamai Technologies, Inc. (AKAM), Cerner Corporation (CERN) and Microchip Technology Inc. (MCHP)
Akamai Technologies (AKAM), Cerner (CERN) and Microchip Technology (MCHP) all reported on their latest quarterly earnings after the bell Tuesday.
Quant Score Keep Cerner (CERN) a Buy
Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.
Quant Score Keep Cerner (CERN) a Buy
Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.
High-Level Earnings Momentum Keep Cerner (CERN) a Buy
Cerner Corp (NASDAQ:CERN) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Cerner (CERN) a Buy on Superior Earnings Momentum
The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Cerner (CERN) Ranking Raised to Buy on Solid Earnings Momentum
The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The shares have been upgraded from a Hold to a Buy in the last week.
Cerner (CERN) a Buy on Solid Quant Score
Portfolio Grader currently ranks Cerner Corp (NASDAQ:CERN) a Buy. Using Louis Navellier's investing methods, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Weakening Earnings Visibility Drops Cerner (CERN) to Hold
Portfolio Grader currently ranks Cerner Corp (NASDAQ:CERN) a Hold. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. CERN has been downgraded from a Buy to a Hold in the last week.
Healthy Quant Score Keeps Cerner (CERN) a Buy
Cerner Corp (NASDAQ:CERN) is one of the 782 companies in the GICS Health Care sector, and a constituent of the 26 company Health Care Technology GICS industry group within this sector. CERN's market value is $24.2 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for CERN puts it 7 among the 26 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 167 among the 782 companies in the sector, and number 1,198 in the nearly 5,000 company Portfolio Grader universe.
Earnings Momentum Keeps Cerner (CERN) a Buy
As one of the 783 companies in the GICS Health Care sector Cerner Corp (NASDAQ:CERN) is a member of the 26 company Health Care Technology GICS industry group within this sector. CERN has a market value of $24.4 billion which is in the top 10% of its industry group. The ranking for CERN by Portfolio Grader places it 9 among the 26 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 226 among the 783 companies in the sector, and number 1,629 in the nearly 5,000 company Portfolio Grader universe.
Shares of Cerner (CERN) Ranked a Hold
Currently, Cerner Corp (NASDAQ:CERN) has a Hold using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CERN has had from Portfolio Grader for 5 months.
Shares of Cerner (CERN) Ranked a Hold
Currently, Cerner Corp (NASDAQ:CERN) has a Hold using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CERN has had from Portfolio Grader for 5 months.
3 Big Stock Charts for Thursday: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN) and Cerner Corporation (CERN)
Apple (AAPL) and Amazon (AMZN) have technical charts that are indicating continued weakness while Cerner (CERN) is flashing buy signals.
3 Big Stock Charts for Friday: Anthem Inc (ANTM), AmerisourceBergen Corp. (ABC) and Cerner Corporation (CERN)
AmerisourceBergen (ABC), Cerner (CERN) and Anthem (ANTM) stock are set to break even higher according to these charts.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
